<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">5570203</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkx390</article-id>
    <article-id pub-id-type="publisher-id">gkx390</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Web Server Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>DEOGEN2: prediction and interactive visualization of single amino acid variant deleteriousness in human proteins</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Raimondi</surname>
          <given-names>Daniele</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
        <xref ref-type="aff" rid="AFF2">2</xref>
        <xref ref-type="aff" rid="AFF3">3</xref>
        <xref ref-type="corresp" rid="COR2"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Tanyalcin</surname>
          <given-names>Ibrahim</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
        <xref ref-type="aff" rid="AFF3">3</xref>
        <xref ref-type="corresp" rid="COR2"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ferté</surname>
          <given-names>Julien</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
        <xref ref-type="aff" rid="AFF4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gazzo</surname>
          <given-names>Andrea</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
        <xref ref-type="aff" rid="AFF2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Orlando</surname>
          <given-names>Gabriele</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
        <xref ref-type="aff" rid="AFF2">2</xref>
        <xref ref-type="aff" rid="AFF3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lenaerts</surname>
          <given-names>Tom</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
        <xref ref-type="aff" rid="AFF2">2</xref>
        <xref ref-type="aff" rid="AFF5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Rooman</surname>
          <given-names>Marianne</given-names>
        </name>
        <xref ref-type="aff" rid="AFF1">1</xref>
        <xref ref-type="aff" rid="AFF4">4</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7470-4324</contrib-id>
        <name>
          <surname>Vranken</surname>
          <given-names>Wim</given-names>
        </name>
        <!--<email>wim.vranken@vub.be</email>-->
        <xref ref-type="aff" rid="AFF1">1</xref>
        <xref ref-type="aff" rid="AFF3">3</xref>
        <xref ref-type="aff" rid="AFF5">5</xref>
        <xref ref-type="corresp" rid="COR1"/>
      </contrib>
    </contrib-group>
    <aff id="AFF1"><label>1</label>Interuniversity Institute of Bioinformatics in Brussels, ULB/VUB, Triomflaan, BC building, 6th floor, CP 263, 1050 Brussels, Belgium</aff>
    <aff id="AFF2"><label>2</label>Machine Learning Group, Université Libre de Bruxelles, Boulevard du Triomphe, CP 212, 1050 Brussels, Belgium</aff>
    <aff id="AFF3"><label>3</label>Structural Biology Brussels, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium</aff>
    <aff id="AFF4"><label>4</label>3BIO-BioInfo Group, Université Libre De Bruxelles, AV Fr. Roosevelt 50, CP 165/61, Brussels 1050, Belgium</aff>
    <aff id="AFF5"><label>5</label>Artificial Intelligence Lab, Vrije Universiteit Brussel, Pleinlaan 2, Brussels 1050, Belgium</aff>
    <author-notes>
      <corresp id="COR1"><label>*</label>To whom correspondence should be addressed. Tel: +32 2 6505943; Email: <email>wim.vranken@vub.be</email></corresp>
      <corresp id="COR2"><label>†</label>These authors contributed equally to this work as first authors.</corresp>
    </author-notes>
    <pub-date pub-type="ppub">
      <day>03</day>
      <month>7</month>
      <year>2017</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2017-05-12">
      <day>12</day>
      <month>5</month>
      <year>2017</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>12</day>
      <month>5</month>
      <year>2017</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
    <volume>45</volume>
    <issue>Web Server issue</issue>
    <fpage>W201</fpage>
    <lpage>W206</lpage>
    <history>
      <date date-type="accepted">
        <day>26</day>
        <month>4</month>
        <year>2017</year>
      </date>
      <date date-type="rev-recd">
        <day>24</day>
        <month>4</month>
        <year>2017</year>
      </date>
      <date date-type="received">
        <day>31</day>
        <month>1</month>
        <year>2017</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license license-type="cc-by-nc" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</uri>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkx390.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>High-throughput sequencing methods are generating enormous amounts of genomic data, giving unprecedented insights into human genetic variation and its relation to disease. An individual human genome contains millions of Single Nucleotide Variants: to discriminate the deleterious from the benign ones, a variety of methods have been developed that predict whether a protein-coding variant likely affects the carrier individual's health. We present such a method, DEOGEN2, which incorporates heterogeneous information about the molecular effects of the variants, the domains involved, the relevance of the gene and the interactions in which it participates. This extensive contextual information is non-linearly mapped into one single deleteriousness score for each variant. Since for the non-expert user it is sometimes still difficult to assess what this score means, how it relates to the encoded protein, and where it originates from, we developed an interactive online framework (<ext-link ext-link-type="uri" xlink:href="http://deogen2.mutaframe.com/">http://deogen2.mutaframe.com/</ext-link>) to better present the DEOGEN2 deleteriousness predictions of all possible variants in all human proteins. The prediction is visualized so both expert and non-expert users can gain insights into the meaning, protein context and origins of each prediction.</p>
    </abstract>
    <counts>
      <page-count count="6"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>High-throughput sequencing methods are generating a huge amount of genomic data (<xref rid="B1" ref-type="bibr">1</xref>), and full genome and exome sequencing techniques have greatly enhanced our knowledge about human genetic variation (<xref rid="B2" ref-type="bibr">2</xref>–<xref rid="B4" ref-type="bibr">4</xref>)). Since information is available for healthy individuals (<xref rid="B5" ref-type="bibr">5</xref>) as well as for patients suffering from various diseases (<xref rid="B6" ref-type="bibr">6</xref>), it is possible to analyse the differences between neutral variants, which are present in a control population and are thus considered benign, and deleterious variants, which lead to a disease phenotype. This copious data stream requires efficient processing and annotation to be useful, and in the case of human genetic diseases, efficient computational methods are necessary to reduce the number of observed variants to a few that are likely causative for the phenotype under scrutiny (<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B7" ref-type="bibr">7</xref>). Many computational tools for identifying these deleterious variants have been developed so far (<xref rid="B8" ref-type="bibr">8</xref>). Although these tools tackle the prediction of the pathogenicity of variants from different angles, they generally use Machine Learning (ML) or statistical methods to learn a discrimination between deleterious and neutral Single Nucleotide Variants (SNVs) resulting in amino-acid substitutions at the protein level (<xref rid="B9" ref-type="bibr">9</xref>–<xref rid="B13" ref-type="bibr">13</xref>). These predictors generally consider different molecular or protein-level aspects that are closely related to possible mechanisms of pathogenicity, such as the evolutionary conservation of the mutated position (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>), the stability change upon mutation (<xref rid="B14" ref-type="bibr">14</xref>), possible structural alterations (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B14" ref-type="bibr">14</xref>) and functional annotations using GO terms (<xref rid="B13" ref-type="bibr">13</xref>). With DEOGEN (<xref rid="B12" ref-type="bibr">12</xref>) we introduced contextualization of the target variants by combining sources of information related to different biological scales, with the aim to better represent the complexity of the relationship between variants and their pathogenicity. We integrated information such as the molecular effect of the variant, the relevance of the mutated gene, its known interaction and the pathways in which it is involved. We showed that this approach improves the quality of the final predictions, but our model did not explain how the final deleteriousness score relates to the other variants on the same protein and where it programmatically originates from.</p>
    <p>We here present DEOGEN2, a predictor of missense SVNs for human proteins that is freely accessible at <ext-link ext-link-type="uri" xlink:href="http://deogen2.mutaframe.com/">http://deogen2.mutaframe.com/</ext-link>. DEOGEN2 positively compares with other state-of-the-art methods (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B15" ref-type="bibr">15</xref>–<xref rid="B17" ref-type="bibr">17</xref>) through the further incorporation of various sources of contextual information, such as early folding predictions and protein domain-oriented features. This performance improvement is confirmed on an independent dataset, evidencing the robustness of DEOGEN2. In addition, we provide interactive visualisation approaches to (i) explain how the deleteriousness score relates to all other variants within that protein and (ii) break down the origin of the score, so enabling the non-expert user to situate the prediction result in its wider biological context. This development enables geneticists and clinicians to move beyond the identification of new disease-causing variants towards their interpretation.</p>
  </sec>
  <sec sec-type="materials|methods" id="SEC2">
    <title>MATERIALS AND METHODS</title>
    <sec id="SEC2-1">
      <title>Datasets</title>
      <p>The main training and testing <bold>Humsavar16</bold> dataset for DEOGEN2 is based on the February 2016 version of Humsavar (<xref rid="B18" ref-type="bibr">18</xref>). From the original 73 266 variants mapped on 12 335 proteins, 7375 unclassified variants were discarded and 27 606 deleterious SNVs and 38 285 neutral SNVs retained. In addition, an independent <bold>Blind</bold> dataset based on Testing Dataset I proposed in (<xref rid="B8" ref-type="bibr">8</xref>), which contains 120 deleterious variants extracted from 57 Nature Genetics publications and 124 neutral variants from (<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B8" ref-type="bibr">8</xref>), was created by filtering out 30 proteins also present in <bold>Humsavar16</bold>, so ensuring complete independence between these datasets.</p>
    </sec>
    <sec id="SEC2-2">
      <title>Features</title>
      <p>The DEOGEN2 features are listed in Table <xref ref-type="table" rid="tbl1">1</xref>; we present only the new and improved features compared to DEOGEN (<xref rid="B12" ref-type="bibr">12</xref>).</p>
      <table-wrap id="tbl1" orientation="portrait" position="float">
        <label>Table 1.</label>
        <caption>
          <title>Summary of the features used in DEOGEN2</title>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">Feature</th>
              <th align="left" rowspan="1" colspan="1">Status</th>
              <th align="left" rowspan="1" colspan="1">Short name</th>
              <th align="left" rowspan="1" colspan="1">Code</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">PROVEAN score (<xref rid="B16" ref-type="bibr">16</xref>)</td>
              <td rowspan="1" colspan="1">From version 1</td>
              <td rowspan="1" colspan="1">PROV</td>
              <td rowspan="1" colspan="1">PR</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Conservation Index (<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B13" ref-type="bibr">13</xref>)</td>
              <td rowspan="1" colspan="1">Improved</td>
              <td rowspan="1" colspan="1">CI</td>
              <td rowspan="1" colspan="1">CI</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Mutant/wildtype log-odd ratio (<xref rid="B12" ref-type="bibr">12</xref>)</td>
              <td rowspan="1" colspan="1">Improved</td>
              <td rowspan="1" colspan="1">LOR</td>
              <td rowspan="1" colspan="1">LO</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Early Folding predictions</td>
              <td rowspan="1" colspan="1">New</td>
              <td rowspan="1" colspan="1">EF</td>
              <td rowspan="1" colspan="1">EF</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">PFAM log-odd score (<xref rid="B17" ref-type="bibr">17</xref>)</td>
              <td rowspan="1" colspan="1">New</td>
              <td rowspan="1" colspan="1">PF</td>
              <td rowspan="1" colspan="1">PF</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Interaction patches annotation (<xref rid="B19" ref-type="bibr">19</xref>)</td>
              <td rowspan="1" colspan="1">New</td>
              <td rowspan="1" colspan="1">INT</td>
              <td rowspan="1" colspan="1">IN</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">RVIS (<xref rid="B20" ref-type="bibr">20</xref>)</td>
              <td rowspan="1" colspan="1">New</td>
              <td rowspan="1" colspan="1">RVIS</td>
              <td rowspan="1" colspan="1">RV</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">GDI (<xref rid="B21" ref-type="bibr">21</xref>)</td>
              <td rowspan="1" colspan="1">New</td>
              <td rowspan="1" colspan="1">GDI</td>
              <td rowspan="1" colspan="1">GD</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Recessiveness index (<xref rid="B22" ref-type="bibr">22</xref>)</td>
              <td rowspan="1" colspan="1">From version 1</td>
              <td rowspan="1" colspan="1">REC</td>
              <td rowspan="1" colspan="1">RE</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Gene essentiality (<xref rid="B23" ref-type="bibr">23</xref>)</td>
              <td rowspan="1" colspan="1">From version 1</td>
              <td rowspan="1" colspan="1">ESS</td>
              <td rowspan="1" colspan="1">ES</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Pathway log-odd score (<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B13" ref-type="bibr">13</xref>)</td>
              <td rowspan="1" colspan="1">Extended data</td>
              <td rowspan="1" colspan="1">PATH</td>
              <td rowspan="1" colspan="1">PA</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <sec id="SEC2-2-1">
        <title>Evolutionary-based features</title>
        <p>The evolutionary-based <bold>CI</bold> (Conservation Index) and <bold>LOR</bold> (Log-Odd Ratio) scores (<xref rid="B12" ref-type="bibr">12</xref>) were improved by switching to hhBlits (<xref rid="B24" ref-type="bibr">24</xref>) from JackHmmer (<xref rid="B25" ref-type="bibr">25</xref>) to generate Multiple Sequence Aligments (MSAs), resulting in (i) MSAs that are faster to compute, (ii) the retrieval of more distant homologs and (iii) generally smaller alignments. The hhBlits MSAs were computed with one iteration and <italic>E</italic>-value =10<sup>−4</sup>, and we added a pre-filtering step to the MSAs before computing CI and LOR scores by removing the sequences with &lt;0.3 coverage and 0.3 Sequence Identity (SI) from the LOR calculation and with &lt;0.1 coverage and 0.1 SI from the CI computation (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Section S1</xref> and <xref ref-type="supplementary-material" rid="sup1">Figures S1 and S2</xref>).</p>
      </sec>
      <sec id="SEC2-2-2">
        <title>Early folding predictions</title>
        <p>Disruptions to the protein folding process are likely to deactivate the function of proteins that should fold. We added a prediction of protein Early Folding (<bold>EF</bold>) residues as a feature in DEOGEN2 to explore this type of molecular information in variant-effect prediction. This method uses predictions from DynaMine (<xref rid="B26" ref-type="bibr">26</xref>) in combination with a Support Vector Machine (SVM) model trained on the data from the Start2Fold dataset (<xref rid="B27" ref-type="bibr">27</xref>) to make its predictions (under review). For each variant the EF is calculated and the difference with the wild type prediction taken as a measure for the impact on the initial steps of the protein's folding process (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S3</xref>).</p>
      </sec>
      <sec id="SEC2-2-3">
        <title>Domain-oriented feature</title>
        <p>PfamScan (<xref rid="B28" ref-type="bibr">28</xref>) was used to obtain domain boundaries and other PFAM (<xref rid="B29" ref-type="bibr">29</xref>) annotations such as coiled-coil regions, repeats, motifs or disordered regions. Similar to (<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B17" ref-type="bibr">17</xref>), the training set was used in cross-validation settings to learn the log-odd ratio of the probability of observing a deleterious or a neutral variant on each PFAM entry (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Section S2</xref> for details). This <bold>PF</bold> scores provide an indication of the tendency of these entries to be involved in deleterious phenotypes (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S4</xref>).</p>
      </sec>
      <sec id="SEC2-2-4">
        <title>Interaction patches</title>
        <p>Annotations on 11 471 known interaction patches for 3627 human proteins were obtained from the INstruct database (<xref rid="B19" ref-type="bibr">19</xref>). For every pair of interacting proteins, INstruct contains an indication of where the interaction patch in each protein, identified from the structure of the complex, is situated in the sequence. Information about whether the variant occurs on a known interaction patch (or not) was included as the <bold>INT</bold> feature (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Figure S5</xref>).</p>
      </sec>
      <sec id="SEC2-2-5">
        <title>Gene-oriented features</title>
        <p>The Residual Variation Intolerance Score (<bold>RVIS</bold>) (<xref rid="B20" ref-type="bibr">20</xref>) and Gene Damage Index (<bold>GDI</bold>) (<xref rid="B21" ref-type="bibr">21</xref>) scores improve the contextualization of whether a variant affects a gene/protein important for human health. GDI is a gene-level metric of the cumulative mutational damage that each gene carries in the general population (<xref rid="B21" ref-type="bibr">21</xref>). Since natural selection acts on genes in function of their relevance for human health, the most frequently mutated genes are more likely to harbor nearly-neutral variants, while variants on least damaged genes are more likely to be disease-related (<xref rid="B21" ref-type="bibr">21</xref>). RVIS (<xref rid="B20" ref-type="bibr">20</xref>) ranks the likelihood of the genes to be disease-causing by comparing the amount of functional variation carried by each gene with respect to the genome-wide average. Genes with low common functional variation are more subject to purifying selection than genes with a higher than average mutational burden, highlighting their functional relevance. (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Figures S6 and S7</xref>)</p>
      </sec>
      <sec id="SEC2-2-6">
        <title>Pathway-oriented feature</title>
        <p>We updated the snp&amp;Go (<xref rid="B13" ref-type="bibr">13</xref>) inspired pathway log-odd score with data from version 31 of ConsensusPathDB (<xref rid="B30" ref-type="bibr">30</xref>), which now contains 4012 human pathways and 131 216 proteins. As previously (<xref rid="B12" ref-type="bibr">12</xref>), we learned the log-odd scores for each pathway in cross-validation settings to obtain new <bold>PATH</bold> scores that are a proxy of the pathways’ sensitivity to deleterious variants.</p>
      </sec>
    </sec>
    <sec id="SEC2-3">
      <title>Machine Learning and Validation</title>
      <p>We contextualized each variant with the features described above, so obtaining 11-dimensional feature vectors for each variant. We used the scikit-learn (<xref rid="B31" ref-type="bibr">31</xref>) implementation of a Random Forest (<xref rid="B32" ref-type="bibr">32</xref>) classifier with 200 trees. The performances on the Humsavar16 dataset were computed in strict 10-fold cross-validation settings. To reduce possible over-fitting due to homologies between proteins in different cross-validation sets, we ensured that proteins in each set share &lt;25% sequence similarity with the proteins in the other nine sets. The RF model was analysed using the <monospace>treeinterpreter</monospace> library (<ext-link ext-link-type="uri" xlink:href="https://github.com/andosa/treeinterpreter">https://github.com/andosa/treeinterpreter</ext-link>), which decomposes each prediction into its feature contributions (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Section S3</xref>). The final model used in the webserver has been trained on the entire Humsavar16 dataset.</p>
    </sec>
    <sec id="SEC2-4">
      <title>Visualization</title>
      <p>The server framework uses the lexicon visualization library, a collection of micro-libraries written using javascript (es5) and the D3 library (v3.5.17) (<xref rid="B33" ref-type="bibr">33</xref>). Each micro library operates on JSON formatted input. Programmatic access to the methods within each visualization object allows user-control and automated synchronization between different objects.</p>
    </sec>
  </sec>
  <sec sec-type="results" id="SEC3">
    <title>RESULTS</title>
    <sec id="SEC3-1">
      <title>Extended contextualization improves the predictions</title>
      <p>The relationship between a variant and the phenotypic outcome at the human individual level involves an extensive network of interactions and feedback that spans different biological scales, from the molecular to organs. An accurate prediction of the deleteriousness of a variant should encompass such information: we therefore improved and extended the multi-level biological contextualization of the target variants and the affected proteins within our model (<xref rid="B12" ref-type="bibr">12</xref>). In particular, we reduced the requirements in terms of homologous sequences in the MSAs to compute the CI and LOR features and improved the REC, ESS and PATH knowledge based features due to dbNFSP (<xref rid="B34" ref-type="bibr">34</xref>) and ConsensusPathDB (<xref rid="B30" ref-type="bibr">30</xref>) updates. We also introduced new strategic pieces of information as features that (i) provide information about the relevance of the mutated residues for the initial steps of the protein's folding process (EF), (ii) quantify the sensitivity of the domain affected by the mutation to deleterious variants (PF) and (iii) improve the gene-level assessment of the relevance of the mutated protein for human health. The incremental contributions of these features are shown in <xref ref-type="supplementary-material" rid="sup1">Supplementary Table S1</xref> and the distributions of their contributions in the final prediction are shown in <xref ref-type="supplementary-material" rid="sup1">Supplementary Figures S8–S18</xref>.</p>
    </sec>
    <sec id="SEC3-2">
      <title>Comparison with other methods</title>
      <p>We compared the DEOGEN2 performance with the current state-of-the-art on the <bold>Humsavar16</bold> dataset for 10 predictors, and on the <bold>Blind</bold> dataset for 14 predictors. The DEOGEN2 performances on <bold>Humsavar16</bold> (Table <xref ref-type="table" rid="tbl2">2</xref>) show that it has the highest Balanced Accuracy (BAC) and the highest MCC, alongside with metaSVM. Note that the performances of the other methods were extracted from dbNSFP (<xref rid="B34" ref-type="bibr">34</xref>) and may be over-estimated since their training set may overlap with Humsavar16, whereas the DEOGEN2 performances were computed in strict cross-validation settings. DEOGEN2 also performs 7% better than our previous DEOGEN model in terms of MCC. On the independent <bold>Blind</bold> dataset (<xref rid="B8" ref-type="bibr">8</xref>), DEOGEN2 has the highest BAC and the highest MCC (Table <xref ref-type="table" rid="tbl3">3</xref>), with the performances of 13 predictors as reported in (<xref rid="B8" ref-type="bibr">8</xref>), plus the recently published M-CAP (<xref rid="B35" ref-type="bibr">35</xref>) included.</p>
      <table-wrap id="tbl2" orientation="portrait" position="float">
        <label>Table 2.</label>
        <caption>
          <title>Comparison of DEOGEN2 cross-validated performances with state of the art predictors on the Humsavar16 dataset</title>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">Method</th>
              <th align="left" rowspan="1" colspan="1">Sen</th>
              <th align="left" rowspan="1" colspan="1">Spe</th>
              <th align="left" rowspan="1" colspan="1">Bac</th>
              <th align="left" rowspan="1" colspan="1">Pre</th>
              <th align="left" rowspan="1" colspan="1">MCC</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">PolyPhen2</td>
              <td rowspan="1" colspan="1">85</td>
              <td rowspan="1" colspan="1">73</td>
              <td rowspan="1" colspan="1">79</td>
              <td rowspan="1" colspan="1">71</td>
              <td rowspan="1" colspan="1">57</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">LRT</td>
              <td rowspan="1" colspan="1">84</td>
              <td rowspan="1" colspan="1">70</td>
              <td rowspan="1" colspan="1">77</td>
              <td rowspan="1" colspan="1">70</td>
              <td rowspan="1" colspan="1">54</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MutationTaster</td>
              <td rowspan="1" colspan="1">
                <bold>94</bold>
              </td>
              <td rowspan="1" colspan="1">70</td>
              <td rowspan="1" colspan="1">82</td>
              <td rowspan="1" colspan="1">70</td>
              <td rowspan="1" colspan="1">63</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MutationAssessor</td>
              <td rowspan="1" colspan="1">81</td>
              <td rowspan="1" colspan="1">71</td>
              <td rowspan="1" colspan="1">76</td>
              <td rowspan="1" colspan="1">69</td>
              <td rowspan="1" colspan="1">52</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">fatHMM</td>
              <td rowspan="1" colspan="1">78</td>
              <td rowspan="1" colspan="1">85</td>
              <td rowspan="1" colspan="1">82</td>
              <td rowspan="1" colspan="1">80</td>
              <td rowspan="1" colspan="1">63</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">PROVEAN</td>
              <td rowspan="1" colspan="1">82</td>
              <td rowspan="1" colspan="1">75</td>
              <td rowspan="1" colspan="1">79</td>
              <td rowspan="1" colspan="1">72</td>
              <td rowspan="1" colspan="1">57</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">metaSVM</td>
              <td rowspan="1" colspan="1">83</td>
              <td rowspan="1" colspan="1">
                <bold>93</bold>
              </td>
              <td rowspan="1" colspan="1">88</td>
              <td rowspan="1" colspan="1">
                <bold>90</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>76</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">fatHMM-MKL</td>
              <td rowspan="1" colspan="1">
                <bold>94</bold>
              </td>
              <td rowspan="1" colspan="1">54</td>
              <td rowspan="1" colspan="1">74</td>
              <td rowspan="1" colspan="1">61</td>
              <td rowspan="1" colspan="1">51</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">SIFT</td>
              <td rowspan="1" colspan="1">85</td>
              <td rowspan="1" colspan="1">68</td>
              <td rowspan="1" colspan="1">77</td>
              <td rowspan="1" colspan="1">67</td>
              <td rowspan="1" colspan="1">53</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">PON-P2</td>
              <td rowspan="1" colspan="1">86</td>
              <td rowspan="1" colspan="1">83</td>
              <td rowspan="1" colspan="1">84</td>
              <td rowspan="1" colspan="1">80</td>
              <td rowspan="1" colspan="1">69</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">VEST3</td>
              <td rowspan="1" colspan="1">88</td>
              <td rowspan="1" colspan="1">87</td>
              <td rowspan="1" colspan="1">87</td>
              <td rowspan="1" colspan="1">82</td>
              <td rowspan="1" colspan="1">74</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">DEOGEN</td>
              <td rowspan="1" colspan="1">77</td>
              <td rowspan="1" colspan="1">92</td>
              <td rowspan="1" colspan="1">84</td>
              <td rowspan="1" colspan="1">85</td>
              <td rowspan="1" colspan="1">71</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>DEOGEN2</bold>
              </td>
              <td rowspan="1" colspan="1">89</td>
              <td rowspan="1" colspan="1">88</td>
              <td rowspan="1" colspan="1">
                <bold>89</bold>
              </td>
              <td rowspan="1" colspan="1">84</td>
              <td rowspan="1" colspan="1">
                <bold>76</bold>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="T2TFN1">
            <p>DEOGEN and DEOGEN2 scores have been computed in-house with a stratified 10-folds cross-validation. DEOGEN2 uses the MCC-optimal deleteriousness threshold &gt;0.45. PON-P2 predictions have been obtained from its web server. All the other scores have been extracted from the 3.2 version of dbNSFP (<xref rid="B34" ref-type="bibr">34</xref>).</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="tbl3" orientation="portrait" position="float">
        <label>Table 3.</label>
        <caption>
          <title>Predictor performances on the Blind dataset</title>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">Method</th>
              <th align="left" rowspan="1" colspan="1">Sen</th>
              <th align="left" rowspan="1" colspan="1">Spe</th>
              <th align="left" rowspan="1" colspan="1">Bac</th>
              <th align="left" rowspan="1" colspan="1">Pre</th>
              <th align="left" rowspan="1" colspan="1">MCC</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">SIFT</td>
              <td rowspan="1" colspan="1">68</td>
              <td rowspan="1" colspan="1">75</td>
              <td rowspan="1" colspan="1">72</td>
              <td rowspan="1" colspan="1">79</td>
              <td rowspan="1" colspan="1">43</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">PolyPhen2 (HVAR)</td>
              <td rowspan="1" colspan="1">88</td>
              <td rowspan="1" colspan="1">67</td>
              <td rowspan="1" colspan="1">78</td>
              <td rowspan="1" colspan="1">78</td>
              <td rowspan="1" colspan="1">57</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">LRT</td>
              <td rowspan="1" colspan="1">88</td>
              <td rowspan="1" colspan="1">66</td>
              <td rowspan="1" colspan="1">77</td>
              <td rowspan="1" colspan="1">78</td>
              <td rowspan="1" colspan="1">57</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Mutation Taster</td>
              <td rowspan="1" colspan="1">
                <bold>94</bold>
              </td>
              <td rowspan="1" colspan="1">74</td>
              <td rowspan="1" colspan="1">84</td>
              <td rowspan="1" colspan="1">83</td>
              <td rowspan="1" colspan="1">70</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Mutation Assessor</td>
              <td rowspan="1" colspan="1">70</td>
              <td rowspan="1" colspan="1">80</td>
              <td rowspan="1" colspan="1">75</td>
              <td rowspan="1" colspan="1">83</td>
              <td rowspan="1" colspan="1">49</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">FatHMM</td>
              <td rowspan="1" colspan="1">55</td>
              <td rowspan="1" colspan="1">91</td>
              <td rowspan="1" colspan="1">73</td>
              <td rowspan="1" colspan="1">90</td>
              <td rowspan="1" colspan="1">48</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">GERP++</td>
              <td rowspan="1" colspan="1">77</td>
              <td rowspan="1" colspan="1">72</td>
              <td rowspan="1" colspan="1">75</td>
              <td rowspan="1" colspan="1">80</td>
              <td rowspan="1" colspan="1">49</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">PhyloP</td>
              <td rowspan="1" colspan="1">76</td>
              <td rowspan="1" colspan="1">73</td>
              <td rowspan="1" colspan="1">75</td>
              <td rowspan="1" colspan="1">80</td>
              <td rowspan="1" colspan="1">49</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">SNAP</td>
              <td rowspan="1" colspan="1">53</td>
              <td rowspan="1" colspan="1">70</td>
              <td rowspan="1" colspan="1">62</td>
              <td rowspan="1" colspan="1">63</td>
              <td rowspan="1" colspan="1">23</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">SNP&amp;GO</td>
              <td rowspan="1" colspan="1">55</td>
              <td rowspan="1" colspan="1">94</td>
              <td rowspan="1" colspan="1">75</td>
              <td rowspan="1" colspan="1">89</td>
              <td rowspan="1" colspan="1">53</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">MutPred</td>
              <td rowspan="1" colspan="1">74</td>
              <td rowspan="1" colspan="1">81</td>
              <td rowspan="1" colspan="1">78</td>
              <td rowspan="1" colspan="1">79</td>
              <td rowspan="1" colspan="1">55</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">CONDEL</td>
              <td rowspan="1" colspan="1">71</td>
              <td rowspan="1" colspan="1">73</td>
              <td rowspan="1" colspan="1">72</td>
              <td rowspan="1" colspan="1">72</td>
              <td rowspan="1" colspan="1">44</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">CADD phred</td>
              <td rowspan="1" colspan="1">79</td>
              <td rowspan="1" colspan="1">74</td>
              <td rowspan="1" colspan="1">77</td>
              <td rowspan="1" colspan="1">81</td>
              <td rowspan="1" colspan="1">53</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">M-CAP</td>
              <td rowspan="1" colspan="1">93</td>
              <td rowspan="1" colspan="1">68</td>
              <td rowspan="1" colspan="1">81</td>
              <td rowspan="1" colspan="1">74</td>
              <td rowspan="1" colspan="1">63</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">DEOGEN</td>
              <td rowspan="1" colspan="1">46</td>
              <td rowspan="1" colspan="1">
                <bold>96</bold>
              </td>
              <td rowspan="1" colspan="1">71</td>
              <td rowspan="1" colspan="1">
                <bold>92</bold>
              </td>
              <td rowspan="1" colspan="1">48</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>DEOGEN2</bold>
              </td>
              <td rowspan="1" colspan="1">87</td>
              <td rowspan="1" colspan="1">86</td>
              <td rowspan="1" colspan="1">
                <bold>87</bold>
              </td>
              <td rowspan="1" colspan="1">87</td>
              <td rowspan="1" colspan="1">
                <bold>73</bold>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="T3TFN1">
            <p>DEOGEN2 scores were computed in-house using the deleteriousness threshold &gt;0.5. M-CAP (<xref rid="B35" ref-type="bibr">35</xref>) scores were downloaded and interpreted using pathogenicity threshold &gt;0.025. All other scores from (<xref rid="B8" ref-type="bibr">8</xref>).</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec id="SEC3-3">
      <title>Visualization of the results</title>
      <p>The DEOGEN2 visualisation process and graphs are described in Figure <xref ref-type="fig" rid="F1">1</xref>. A sample variant can be loaded by clicking on the ‘Load Example’ button: this displays the N45S variant in Transforming Growth Factor-Beta Receptor 1 (TGFBR1), with Uniprot ID P36897 and RefSeq ID NP_004603.1. Variants of this protein have been linked to Loeys-Dietz Syndrome and susceptibility to multiple self-healing squamous epithelioma (<xref rid="B36" ref-type="bibr">36</xref>,<xref rid="B37" ref-type="bibr">37</xref>), and we will discuss the information that the web server provides around this example of a disease-causing variant.</p>
      <fig id="F1" orientation="portrait" position="float">
        <label>Figure 1.</label>
        <caption>
          <p>Overview of the DEOGEN2 web server visualization. (1) The user starts to enter a Uniprot ID or sequence, which activates a dropdown list from which a human protein is selected. After pressing the play button, the user can navigate the sequence (2) to create and submit a variant for this sequence. After pressing ‘Submit sequence’, the variant is visualized in the page report (3) which contains two sections. The General section displays the change between the wild-type and variant amino acid, with the chemical structures of both shown, and the difference between the amino acids expressed on (<bold>A</bold>) the dashboard as a percentage; clicking on the percentage bar will show the breakdown of these components. The DEOGEN2 section shows the DEOGEN2 score with (<bold>B</bold>) a breakdown of the contribution of each machine learning feature, so informing the user about which contextual information was most important to reach the final score, and an overview of the raw features scores used as input for the machine learning. Section (<bold>C</bold>) shows the distribution of all the variant scores in this protein, including in a heat map format (not shown). Information on data points is obtained by hovering over them, the visualization can be changed by clicking on the buttons or the graph icon in the top right corner.</p>
        </caption>
        <graphic xlink:href="gkx390fig1"/>
      </fig>
      <p>The ‘General’ section of the page report (Figure <xref ref-type="fig" rid="F1">1</xref>.3) shows that the amino acids are relatively similar; both are polar and hydrophilic amino acids with only a small size difference. The calculation of the percentages here is based on a normalised score of the differences in the BLOSUM62 matrix change, the amino acid size, hydrophobicity and charge. Despite the similarity of the amino acids, the ‘DEOGEN2’ section shows that this variant is likely deleterious with an overall score of 0.927 (0 is benign, 1 is deleterious, with the prediction cutoff point at 0.5). The dashboard highlights the key features that contributed to this score; clicking on the percentage bar will display a breakdown of these components.</p>
      <p>The first graph underneath (Figure <xref ref-type="fig" rid="F1">1</xref>.Breakdown) shows the machine learning contributions in detail: on the x-axis each feature code is listed (Table <xref ref-type="table" rid="tbl1">1</xref>), while the y-axis indicates the contribution of the corresponding feature toward the final decision: positive values vote toward deleteriousness, negative values toward a benign variant (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Section S3</xref>). Clicking on the top-right graph button will link the points to better illustrate the decision profile for the variant of interest. In the case of variant N45S, the plot indicates that, among the evolutionary features, PROVEAN (PR) pushed the decision towards the deleterious class while CI (CI) and LOR (LO) slightly pushed towards neutrality. This behavior highlights the complementarity of the different evolutionary features used in our model: in this case the wider sequence context (PR) points to deleteriousness of the variant, not its individual position in the sequence. The contribution of the PFAM log-odd score (PF) strongly pushed the decision towards the deleterious class, due to the fact that N45S variant falls into the Activin receptor domain (PF01064.20), whose sensitivity to deleterious variants is reasonably high (log-odd score of 1.79). Among the protein-oriented features, only REC (RE) provided a noticeable contribution, indicating this protein is encoded by a gene that can cause recessive disorders when homozygously lost.</p>
      <p>The next graph shows the raw feature scores that are the input for the prediction algorithm. Next, the distribution of the scores of all the variants in the same protein is shown (Figure <xref ref-type="fig" rid="F1">1</xref>.Distribution), with the y-axis showing the frequency and the x-axis the overall DEOGEN2 score. Clicking on the marker button enables the user to evaluate where their variant is situated in this distribution; in the case of TGFBR1, the protein contains variants predicted as deleterious but a larger proportion has scores below the 0.5 threshold and are therefore likely benign. By clicking on the ‘Local’ button the user can scroll through the sequence to see where the most deleterious or benign regions are located. The sequence position can be identified by hovering over the yellow highlighted sections. For example, the region around residue 193 is highly deleterious, whereas variants in the region around residue 360 are likely benign. Finally, this information is represented in a heat map that visualizes all variants for each sequence position. This enables the user to identify ‘hot spots’ in the sequence, and pinpoint which amino acid variants are predicted as the most deleterious.</p>
    </sec>
  </sec>
  <sec id="SEC4">
    <title>DISCUSSION AND CONCLUSION</title>
    <p>With the continuing performance improvement of variant effect predictors, partially due to the integration of increasing amounts of data at different biological levels, we think the time is right to shift their focus to the what, how and where, so generating understanding about what the variant means. With the DEOGEN2 webserver, we provide visualization of the meaning, protein context and origins of each prediction to enable the user to make a more informed decision or hypothesis about a particular variant instead of having to rely on a single all-encompassing score.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sup1">
      <label>Supplementary Data</label>
      <media xlink:href="gkx390_Supp.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec id="SEC5">
    <title>SUPPLEMENTARY DATA</title>
    <p><xref ref-type="supplementary-material" rid="sup1">Supplementary Data</xref> are available at NAR Online.</p>
  </sec>
  <sec id="SEC6">
    <title>FUNDING</title>
    <p>Agency for Innovation by Science and Technology in Flanders (IWT) (to D.R.); M.R. is Research Director at the FNRS Fund for Scientific Research; the European Regional Development Fund (ERDF) and Brussels-Capital Region-Innoviris within the framework of the Operational Programme 2014–2020 [ERDF-2020 project ICITY-RDI.BRU]. Funding for open access charge: The ERDF-2020 project ICITY-RDI.BRU grant.</p>
    <p><italic>Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Dijk</surname><given-names>E.L.</given-names></name>, <name name-style="western"><surname>Auger</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Jaszczyszyn</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Thermes</surname><given-names>C.</given-names></name></person-group><article-title>Ten years of next-generation sequencing technology</article-title>. <source>Trends Genet.</source><year>2014</year>; <volume>30</volume>:<fpage>418</fpage>–<lpage>426</lpage>.<pub-id pub-id-type="pmid">25108476</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bamshad</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>S.B.</given-names></name>, <name name-style="western"><surname>Bigham</surname><given-names>A.W.</given-names></name>, <name name-style="western"><surname>Tabor</surname><given-names>H.K.</given-names></name>, <name name-style="western"><surname>Emond</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Nickerson</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Shendure</surname><given-names>J.</given-names></name></person-group><article-title>Exome sequencing as a tool for Mendelian disease gene discovery</article-title>. <source>Nat. Rev. Genet.</source><year>2011</year>; <volume>12</volume>:<fpage>745</fpage>–<lpage>755</lpage>.<pub-id pub-id-type="pmid">21946919</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boycott</surname><given-names>K.M.</given-names></name>, <name name-style="western"><surname>Vanstone</surname><given-names>M.R.</given-names></name>, <name name-style="western"><surname>Bulman</surname><given-names>D.E.</given-names></name>, <name name-style="western"><surname>MacKenzie</surname><given-names>A.E.</given-names></name></person-group><article-title>Rare-disease genetics in the era of next-generation sequencing: discovery to translation</article-title>. <source>Nat. Rev. Genet.</source><year>2013</year>; <volume>14</volume>:<fpage>681</fpage>–<lpage>691</lpage>.<pub-id pub-id-type="pmid">23999272</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnston</surname><given-names>J.J.</given-names></name>, <name name-style="western"><surname>Biesecker</surname><given-names>L.G.</given-names></name></person-group><article-title>Databases of genomic variation and phenotypes: existing resources and future needs</article-title>. <source>Hum. Mol. Genet.</source><year>2013</year>; <volume>22</volume>:<fpage>R27</fpage>–<lpage>R31</lpage>.<pub-id pub-id-type="pmid">23962721</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>1000 Genomes Project Consortium</collab><name name-style="western"><surname>Abecasis</surname><given-names>G.R.</given-names></name>, <name name-style="western"><surname>Altshuler</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Auton</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Brooks</surname><given-names>L.D.</given-names></name>, <name name-style="western"><surname>Durbin</surname><given-names>R.M.</given-names></name>, <name name-style="western"><surname>Gibbs</surname><given-names>R.A.</given-names></name>, <name name-style="western"><surname>Hurles</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>McVean</surname><given-names>G.A.</given-names></name></person-group><article-title>A map of human genome variation from population-scale sequencing</article-title>. <source>Nature</source>. <year>2010</year>; <volume>467</volume>:<fpage>1061</fpage>–<lpage>1073</lpage>.<pub-id pub-id-type="pmid">20981092</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stenson</surname><given-names>P.D.</given-names></name>, <name name-style="western"><surname>Ball</surname><given-names>E.V.</given-names></name>, <name name-style="western"><surname>Mort</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>A.D.</given-names></name>, <name name-style="western"><surname>Shiel</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>N.S.</given-names></name>, <name name-style="western"><surname>Abeysinghe</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Krawczak</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>D.N.</given-names></name></person-group><article-title>Human gene mutation database (HGMD<sup>®</sup>): 2003 update</article-title>. <source>Hum. Mutat.</source><year>2003</year>; <volume>21</volume>:<fpage>577</fpage>–<lpage>581</lpage>.<pub-id pub-id-type="pmid">12754702</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pabinger</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Dander</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Fischer</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Snajder</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Sperk</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Efremova</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Krabichler</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Speicher</surname><given-names>M.R.</given-names></name>, <name name-style="western"><surname>Zschocke</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Trajanoski</surname><given-names>Z.</given-names></name></person-group><article-title>A survey of tools for variant analysis of next-generation genome sequencing data</article-title>. <source>Brief. Bioinform.</source><year>2014</year>; <volume>15</volume>:<fpage>256</fpage>–<lpage>278</lpage>.<pub-id pub-id-type="pmid">23341494</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Jian</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Gibbs</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Boerwinkle</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name></person-group><article-title>Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies</article-title>. <source>Hum. Mol. Genet.</source><year>2015</year>; <volume>24</volume>:<fpage>2125</fpage>–<lpage>2137</lpage>.<pub-id pub-id-type="pmid">25552646</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adzhubei</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Daniel</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Sunyaev</surname><given-names>S.R.</given-names></name></person-group><article-title>Predicting functional effect of human missense mutations using PolyPhen2</article-title>. <source>Curr. Protoc. Hum. Genet.</source><year>2013</year>; <comment>doi:10.1002/0471142905.hg0720s76</comment>.</mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>P.C.</given-names></name>, <name name-style="western"><surname>Henikoff</surname><given-names>S.</given-names></name></person-group><article-title>SIFT: Predicting amino acid changes that affect protein function</article-title>. <source>Nucleic Acids Res.</source><year>2003</year>; <volume>31</volume>:<fpage>3812</fpage>–<lpage>3814</lpage>.<pub-id pub-id-type="pmid">12824425</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Krishnan</surname><given-names>V.G.</given-names></name>, <name name-style="western"><surname>Mort</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Xin</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Kamati</surname><given-names>K.K.</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>D.N.</given-names></name>, <name name-style="western"><surname>Mooney</surname><given-names>S.D.</given-names></name>, <name name-style="western"><surname>Radivojac</surname><given-names>P.</given-names></name></person-group><article-title>Automated inference of molecular mechanisms of disease from amino acid substitutions</article-title>. <source>Bioinformatics</source>. <year>2009</year>; <volume>25</volume>:<fpage>2744</fpage>–<lpage>2750</lpage>.<pub-id pub-id-type="pmid">19734154</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raimondi</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Gazzo</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Rooman</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lenaerts</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Vranken</surname><given-names>W.F.</given-names></name></person-group><article-title>Multi-level biological characterization of exomic variants at the protein level significantly improves the identification of their deleterious effects</article-title>. <source>Bioinformatics</source>. <year>2016</year>; <volume>32</volume>:<fpage>1797</fpage>–<lpage>1804</lpage>.<pub-id pub-id-type="pmid">27153718</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calabrese</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Capriotti</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Fariselli</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Martelli</surname><given-names>P.L.</given-names></name>, <name name-style="western"><surname>Casadio</surname><given-names>R.</given-names></name></person-group><article-title>Functional annotations improve the predictive score of human disease-related mutations in proteins</article-title>. <source>Hum. Mutat.</source><year>2009</year>; <volume>30</volume>:<fpage>1237</fpage>–<lpage>1244</lpage>.<pub-id pub-id-type="pmid">19514061</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Baets</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Van Durme</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Reumers</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Maurer-Stroh</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Vanhee</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Dopazo</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Schymkowitz</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Rousseau</surname><given-names>F.</given-names></name></person-group><article-title>SNPeffect 4.0: on-line prediction of molecular and structural effects of protein-coding variants</article-title>. <source>Nucleic Acids Res.</source><year>2012</year>; <volume>40</volume>:<fpage>D935</fpage>–<lpage>D939</lpage>.<pub-id pub-id-type="pmid">22075996</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwarz</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Rödelsperger</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Schuelke</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Seelow</surname><given-names>D.</given-names></name></person-group><article-title>MutationTaster evaluates disease-causing potential of sequence alterations</article-title>. <source>Nat. Methods</source>. <year>2010</year>; <volume>7</volume>:<fpage>575</fpage>–<lpage>576</lpage>.<pub-id pub-id-type="pmid">20676075</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Sims</surname><given-names>G.E.</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>J. R.</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>A.P.</given-names></name></person-group><article-title>Predicting the functional effect of amino acid substitutions and indels</article-title>. <source>PLoS One</source>. <year>2012</year>; <volume>7</volume>:<fpage>e46688</fpage>.<pub-id pub-id-type="pmid">23056405</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shihab</surname><given-names>H.A.</given-names></name>, <name name-style="western"><surname>Gough</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>D.N.</given-names></name>, <name name-style="western"><surname>Stenson</surname><given-names>P.D.</given-names></name>, <name name-style="western"><surname>Barker</surname><given-names>G.L.A.</given-names></name>, <name name-style="western"><surname>Edwards</surname><given-names>K.J.</given-names></name>, <name name-style="western"><surname>Gaunt</surname><given-names>T. R.</given-names></name></person-group><article-title>Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models</article-title>. <source>Hum. Mut.</source><year>2013</year>; <volume>34</volume>:<fpage>57</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">23033316</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><collab>UniProt-Consortium</collab><article-title>The Universal Protein Resource (UniProt) in 2010</article-title>. <source>Nucleic Acids Res.</source><year>2010</year>; <volume>38</volume>:<fpage>D142</fpage>–<lpage>D148</lpage>.<pub-id pub-id-type="pmid">19843607</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meyer</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>H.</given-names></name></person-group><article-title>INstruct: a database of high-quality 3D structurally resolved protein interactome networks</article-title>. <source>Bioinformatics</source>. <year>2013</year>; <volume>29</volume>:<fpage>1577</fpage>–<lpage>1579</lpage>.<pub-id pub-id-type="pmid">23599502</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petrovski</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Heinzen</surname><given-names>E.L.</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>A.S.</given-names></name>, <name name-style="western"><surname>Goldstein</surname><given-names>D.B.</given-names></name></person-group><article-title>Genic intolerance to functional variation and the interpretation of personal genomes</article-title>. <source>PLoS Genet.</source><year>2013</year>; <volume>9</volume>:<fpage>e1003709</fpage>.<pub-id pub-id-type="pmid">23990802</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Itan</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Boisson</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Patin</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Bolze</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Moncada-Vélez</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ciancanelli</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Lafaille</surname><given-names>F.G.</given-names></name>, <name name-style="western"><surname>Markle</surname><given-names>J.G.</given-names></name><etal/></person-group><article-title>The human gene damage index as a gene-level approach to prioritizing exome variants</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <year>2015</year>; <volume>112</volume>:<fpage>13615</fpage>–<lpage>13620</lpage>.<pub-id pub-id-type="pmid">26483451</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>MacArthur</surname><given-names>D.G.</given-names></name>, <name name-style="western"><surname>Balasubramanian</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Frankish</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Walter</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Jostins</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Habegger</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Pickrell</surname><given-names>J.K.</given-names></name>, <name name-style="western"><surname>Montgomery</surname><given-names>S.B.</given-names></name><etal/></person-group><article-title>A systematic survey of loss-of-function variants in human protein-coding genes</article-title>. <source>Science</source>. <year>2012</year>; <volume>335</volume>:<fpage>823</fpage>–<lpage>828</lpage>.<pub-id pub-id-type="pmid">22344438</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Georgi</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Voight</surname><given-names>B.F.</given-names></name>, <name name-style="western"><surname>Buan</surname><given-names>M.</given-names></name></person-group><article-title>From mouse to human: evolutionary genomics analysis of human orthologs of essential genes</article-title>. <source>PLoS Genet.</source><year>2013</year>; <volume>9</volume>:<fpage>e1003484</fpage>.<pub-id pub-id-type="pmid">23675308</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Remmert</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Biegert</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hauser</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Söding</surname><given-names>J.</given-names></name></person-group><article-title>HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment</article-title>. <source>Nat. Methods</source>. <year>2012</year>; <volume>9</volume>:<fpage>173</fpage>–<lpage>175</lpage>.</mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eddy</surname><given-names>S.R.</given-names></name></person-group><article-title>Accelerated profile HMM searches</article-title>. <source>PLoS Comput. Biol.</source><year>2011</year>; <volume>7</volume>:<fpage>e1002195</fpage>.<pub-id pub-id-type="pmid">22039361</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cilia</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Pancsa</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Tompa</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Lenaerts</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Vranken</surname><given-names>W.F.</given-names></name></person-group><article-title>From protein sequence to dynamics and disorder with DynaMine</article-title>. <source>Nat. Commun.</source><year>2013</year>; <volume>4</volume>:<fpage>2741</fpage>.<pub-id pub-id-type="pmid">24225580</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pancsa</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Varadi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tompa</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Vranken</surname><given-names>W.F.</given-names></name></person-group><article-title>Start2Fold: a database of hydrogen/deuterium exchange data on protein folding and stability</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>44</volume>:<fpage>D429</fpage>–<lpage>D434</lpage>.<pub-id pub-id-type="pmid">26582925</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mistry</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bateman</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Finn</surname><given-names>R.D.</given-names></name></person-group><article-title>Predicting active site residue annotations in the Pfam database</article-title>. <source>BMC Bioinformatics</source>. <year>2007</year>; <volume>8</volume>:<fpage>298</fpage>.<pub-id pub-id-type="pmid">17688688</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finn</surname><given-names>R.D.</given-names></name>, <name name-style="western"><surname>Coggill</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Eberhardt</surname><given-names>R.Y.</given-names></name>, <name name-style="western"><surname>Eddy</surname><given-names>S.R.</given-names></name>, <name name-style="western"><surname>Mistry</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Mitchell</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Potter</surname><given-names>S.C.</given-names></name>, <name name-style="western"><surname>Punta</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Qureshi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sangrador-Vegas</surname><given-names>A.</given-names></name><etal/></person-group><article-title>The Pfam protein families database: towards a more sustainable future</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>44</volume>:<fpage>D279</fpage>–<lpage>D285</lpage>.<pub-id pub-id-type="pmid">26673716</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamburov</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Stelzl</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Lehrach</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Herwig</surname><given-names>R.</given-names></name></person-group><article-title>The ConsensusPathDB interaction database: 2013 update</article-title>. <source>Nucleic Acids Res.</source><year>2013</year>; <volume>41</volume>:<fpage>D793</fpage>–<lpage>D800</lpage>.<pub-id pub-id-type="pmid">23143270</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pedregosa</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Varoquaux</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Gramfort</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Michel</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Thirion</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Grisel</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Blondel</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Prettenhofer</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Dubourg</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Scikit-learn: machine learning in Python</article-title>. <source>JMLR</source>. <year>2011</year>; <volume>12</volume>:<fpage>2825</fpage>–<lpage>2830</lpage>.</mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Breiman</surname><given-names>L.</given-names></name></person-group><article-title>Random forests</article-title>. <source>Mach. Learn.</source><year>2001</year>; <volume>45</volume>:<fpage>532</fpage>.</mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bostock</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ogievetsky</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Heer</surname><given-names>J.</given-names></name></person-group><article-title>D3 data-driven documents</article-title>. <source>IEEE Trans. Visual. Comp. Graph.</source><year>2011</year>; <volume>17</volume>:<fpage>2301</fpage>–<lpage>2309</lpage>.</mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Boerwinkle</surname><given-names>E.</given-names></name></person-group><article-title>dbNSFP v3.0: a one-stop database of functional predictions and annotations for human non-synonymous and splice site SNVs</article-title>. <source>Hum. Mutat.</source><year>2016</year>; <volume>37</volume>:<fpage>235</fpage>–<lpage>241</lpage>.<pub-id pub-id-type="pmid">26555599</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jagadeesh</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Wenger</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Berger</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Guturu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Stenson</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Bernstein</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bejerano</surname><given-names>G.</given-names></name></person-group><article-title>M-CAP eliminates a majority of variants with uncertain significance in clinical exomes at high sensitivity</article-title>. <source>Nat. Genet.</source><year>2016</year>; <volume>48</volume>:<fpage>1581</fpage>–<lpage>1586</lpage>.<pub-id pub-id-type="pmid">27776117</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goudie</surname><given-names>D.R.</given-names></name>, <name name-style="western"><surname>D’Alessandro</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Merriman</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Szeverenyi</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Avery</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>O’Connor</surname><given-names>B.D.</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>S.F.</given-names></name>, <name name-style="western"><surname>Coats</surname><given-names>S.E.</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1</article-title>. <source>Nat. Genet.</source><year>2011</year>; <volume>43</volume>:<fpage>365</fpage>–<lpage>369</lpage>.<pub-id pub-id-type="pmid">21358634</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loeys</surname><given-names>B.L.</given-names></name>, <name name-style="western"><surname>Schwarze</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Holm</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Callewaert</surname><given-names>B.L.</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G.H.</given-names></name>, <name name-style="western"><surname>Pannu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>De Backer</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>Oswald</surname><given-names>G.L.</given-names></name>, <name name-style="western"><surname>Symoens</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Manouvrier</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Aneurysm syndromes caused by mutations in the TGF-beta receptor</article-title>. <source>N. Engl. J. Med.</source><year>2006</year>; <volume>355</volume>:<fpage>788</fpage>–<lpage>798</lpage>.<pub-id pub-id-type="pmid">16928994</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
